The results include a $23.1 million charge for the impairment of goodwill and a $1.8 million writeoff of
customer
lists associated with the acquisitions of ETMA and AVT, respectively.
TFAS also took a $1.6 million charge for excess inventory and
transition issues relating to completion of the move of the display
business from the company's factory in Manila to a factory in Beijing.
For
the quarter, the cost of sales was $42.5 million, up from $41 million
last year. Gross margin was a loss of 0.1, versus 1.4 last year.
Jack
Saltich, president and chief executive, said in a statement, "We have
been concentrating our efforts this year on streamlining our global
manufacturing operations and correcting issues in our Redmond factory.
Optimizing our global infrastructure has taken a significant effort. I
believe we are starting to see success from these endeavors."
Separately, TFS named Leslie Honda regulatory affairs director, a new post. Honda was vice president of quality and regulatory for ClearMedical Inc., a medical devices reprocessor.